Published in Front Med (Lausanne) on July 24, 2017
Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med (2006) 13.74
Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol (2002) 10.15
Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet (2006) 9.99
New insights into atopic dermatitis. J Clin Invest (2004) 5.09
Calcium-regulated differentiation of normal human epidermal keratinocytes in chemically defined clonal culture and serum-free serial culture. J Invest Dermatol (1983) 5.05
IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J Immunol (2005) 4.49
Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema. Nat Genet (2007) 3.94
Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β. Nature (2012) 3.85
Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J Exp Med (2007) 3.66
IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells. J Exp Med (2007) 3.66
Thymic stromal lymphopoietin: master switch for allergic inflammation. J Exp Med (2006) 3.25
Possible pathogenic role of Th17 cells for atopic dermatitis. J Invest Dermatol (2008) 3.11
IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. J Allergy Clin Immunol (2009) 2.77
Sensing the outside world: TSLP regulates barrier immunity. Nat Immunol (2010) 2.72
Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev (2011) 2.62
Epidermal barrier dysfunction in atopic dermatitis. J Invest Dermatol (2009) 2.43
Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis. J Allergy Clin Immunol (2003) 2.21
Induction of IL-4 expression in CD4(+) T cells by thymic stromal lymphopoietin. J Immunol (2007) 2.19
Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march. J Allergy Clin Immunol (2006) 2.09
Atopic dermatitis. Ann Dermatol (2010) 2.07
New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions. J Allergy Clin Immunol (2006) 2.06
Cutting edge: direct action of thymic stromal lymphopoietin on activated human CD4+ T cells. J Immunol (2007) 2.03
Th2 Cytokines and Atopic Dermatitis. J Clin Cell Immunol (2011) 1.91
Low expression of the IL-23/Th17 pathway in atopic dermatitis compared to psoriasis. J Immunol (2008) 1.90
Cutting Edge: Proinflammatory and Th2 cytokines synergize to induce thymic stromal lymphopoietin production by human skin keratinocytes. J Immunol (2007) 1.90
Animal models of atopic dermatitis. J Invest Dermatol (2009) 1.80
Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6. Clin Immunol (2007) 1.77
Guidelines for treatment of atopic eczema (atopic dermatitis) part I. J Eur Acad Dermatol Venereol (2012) 1.77
Skin-derived TSLP triggers progression from epidermal-barrier defects to asthma. PLoS Biol (2009) 1.76
Cytokine milieu modulates release of thymic stromal lymphopoietin from human keratinocytes stimulated with double-stranded RNA. J Allergy Clin Immunol (2008) 1.74
The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch. Cell (2013) 1.71
The atopic march: progression from atopic dermatitis to allergic rhinitis and asthma. Allergy Asthma Immunol Res (2011) 1.69
Collagen/chitosan porous scaffolds with improved biostability for skin tissue engineering. Biomaterials (2003) 1.67
Epidermal nerve fibers modulate keratinocyte growth via neuropeptide signaling in an innervated skin model. J Invest Dermatol (2013) 1.67
Thymic stromal lymphopoietin overproduced by keratinocytes in mouse skin aggravates experimental asthma. Proc Natl Acad Sci U S A (2009) 1.63
Risk of developing asthma in young children with atopic eczema: a systematic review. J Allergy Clin Immunol (2007) 1.61
Psoriasis: what we have learned from mouse models. Nat Rev Rheumatol (2010) 1.61
Knockdown of filaggrin impairs diffusion barrier function and increases UV sensitivity in a human skin model. J Invest Dermatol (2010) 1.59
Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis. J Allergy Clin Immunol (2012) 1.56
Mechanisms regulating skin immunity and inflammation. Nat Rev Immunol (2014) 1.53
Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis. J Allergy Clin Immunol (2009) 1.50
Cell density and culture factors regulate keratinocyte commitment to differentiation and expression of suprabasal K1/K10 keratins. J Invest Dermatol (1995) 1.48
Stress-induced changes in skin barrier function in healthy women. J Invest Dermatol (2001) 1.48
Caspase-14 reveals its secrets. J Cell Biol (2008) 1.47
Development of a stratum corneum and barrier function in an organotypic skin culture. Arch Dermatol Res (1993) 1.43
Cell death by cornification. Biochim Biophys Acta (2013) 1.40
Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol (2009) 1.38
Influence of Th2 Cytokines on the Cornified Envelope, Tight Junction Proteins, and ?-Defensins in Filaggrin-Deficient Skin Equivalents. J Invest Dermatol (2015) 1.38
Thymic stromal lymphopoietin and allergic disease. J Allergy Clin Immunol (2012) 1.33
New concept of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy, and pruritus as a trinity. J Dermatol Sci (2013) 1.31
Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin. J Allergy Clin Immunol (2013) 1.30
TSLP produced by keratinocytes promotes allergen sensitization through skin and thereby triggers atopic march in mice. J Invest Dermatol (2012) 1.29
Epidemiology of atopic dermatitis and atopic march in children. Immunol Allergy Clin North Am (2010) 1.28
Large-scale DNA microarray analysis of atopic skin lesions shows overexpression of an epidermal differentiation gene cluster in the alternative pathway and lack of protective gene expression in the cornified envelope. Br J Dermatol (2005) 1.21
Thymic stromal lymphopoietin. Ann N Y Acad Sci (2010) 1.21
The structure of normal skin and the morphology of atopic eczema. J Invest Dermatol (1976) 1.18
TSLP enhances the function of helper type 2 cells. Eur J Immunol (2011) 1.17
IL-25 in atopic dermatitis: a possible link between inflammation and skin barrier dysfunction? J Invest Dermatol (2010) 1.16
Comparison of human skin or epidermis models with human and animal skin in in-vitro percutaneous absorption. Int J Pharm (2001) 1.16
FLG mutations in ichthyosis vulgaris and atopic eczema: spectrum of mutations and population genetics. Br J Dermatol (2009) 1.15
Interleukin-4 suppresses the enhancement of ceramide synthesis and cutaneous permeability barrier functions induced by tumor necrosis factor-alpha and interferon-gamma in human epidermis. J Invest Dermatol (2005) 1.15
Overexpression of thymic stromal lymphopoietin in allergic rhinitis. Acta Otolaryngol (2009) 1.13
Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines. J Allergy Clin Immunol (2001) 1.11
Increased number of immunoreactive nerve fibers in atopic dermatitis. J Allergy Clin Immunol (1992) 1.09
Analysis of SPINK 5, KLK 7 and FLG genotypes in a French atopic dermatitis cohort. Acta Derm Venereol (2007) 1.06
Global expression profiling in atopic eczema reveals reciprocal expression of inflammatory and lipid genes. PLoS One (2008) 1.06
Tissue-engineered skin substitutes: from in vitro constructs to in vivo applications. Biotechnol Appl Biochem (2004) 1.04
Skin barrier function in healthy subjects and patients with atopic dermatitis in relation to filaggrin loss-of-function mutations. J Invest Dermatol (2010) 1.04
Granulocyte macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis. Implications for sustained dendritic cell activation in the skin. J Clin Invest (1997) 1.04
A simple reconstructed human epidermis: preparation of the culture model and utilization in in vitro studies. Arch Dermatol Res (2004) 1.03
IL-31 regulates differentiation and filaggrin expression in human organotypic skin models. J Allergy Clin Immunol (2011) 1.02
Cutaneous nerves in atopic dermatitis. A histological, immunohistochemical and electron microscopic study. Virchows Arch (1998) 1.01
Early cutaneous gene transcription changes in adult atopic dermatitis and potential clinical implications. Exp Dermatol (2007) 0.99
Effects of fibroblasts and microenvironment on epidermal regeneration and tissue function in long-term skin equivalents. Eur J Cell Biol (2007) 0.99
A role for Th17 cells in the immunopathogenesis of atopic dermatitis? J Invest Dermatol (2008) 0.99
IL-17 downregulates filaggrin and affects keratinocyte expression of genes associated with cellular adhesion. Exp Dermatol (2012) 0.97
Causes of epidermal filaggrin reduction and their role in the pathogenesis of atopic dermatitis. J Allergy Clin Immunol (2014) 0.96
Flagellin induces the expression of thymic stromal lymphopoietin in human keratinocytes via toll-like receptor 5. Int Arch Allergy Immunol (2010) 0.96
The role of thymic stromal lymphopoietin in the immunopathogenesis of atopic dermatitis. Clin Exp Allergy (2011) 0.95
Histamine suppresses epidermal keratinocyte differentiation and impairs skin barrier function in a human skin model. Allergy (2012) 0.94
Leiden reconstructed human epidermal model as a tool for the evaluation of the skin corrosion and irritation potential according to the ECVAM guidelines. Toxicol In Vitro (2008) 0.94
Effect of gestational smoke exposure on atopic dermatitis in the offspring. Pediatr Allergy Immunol (2008) 0.94
Evolution of three dimensional skin equivalent models reconstructed in vitro by tissue engineering. Eur J Dermatol (2008) 0.94
Staphylococcus aureus membrane and diacylated lipopeptide induce thymic stromal lymphopoietin in keratinocytes through the Toll-like receptor 2-Toll-like receptor 6 pathway. J Allergy Clin Immunol (2010) 0.93
Interleukin-22 downregulates filaggrin expression and affects expression of profilaggrin processing enzymes. Br J Dermatol (2011) 0.93
The Role of TSLP in IL-13-induced atopic march. Sci Rep (2011) 0.92
Knock-down of filaggrin does not affect lipid organization and composition in stratum corneum of reconstructed human skin equivalents. Exp Dermatol (2013) 0.92
Type 2 helper T-cell cytokines induce morphologic and molecular characteristics of atopic dermatitis in human skin equivalent. Am J Pathol (2011) 0.92
Molecular diagnostics of psoriasis, atopic dermatitis, allergic contact dermatitis and irritant contact dermatitis. Br J Dermatol (2009) 0.91
Keratinocytes under Fire of Proinflammatory Cytokines: Bona Fide Innate Immune Cells Involved in the Physiopathology of Chronic Atopic Dermatitis and Psoriasis. J Allergy (Cairo) (2012) 0.91
Reciprocal regulation of permeability through a cultured keratinocyte sheet by IFN-gamma and IL-4. Cytokine (2004) 0.90
TNF-α and Th2 cytokines induce atopic dermatitis-like features on epidermal differentiation proteins and stratum corneum lipids in human skin equivalents. J Invest Dermatol (2014) 0.89
Skin pH: from basic science to basic skin care. Acta Derm Venereol (2013) 0.89
Designed three-dimensional collagen scaffolds for skin tissue regeneration. Tissue Eng Part C Methods (2010) 0.88
Injury to the stratum corneum induces in vivo expression of human thymic stromal lymphopoietin in the epidermis. J Invest Dermatol (2010) 0.86
Hyaluronan metabolism in human keratinocytes and atopic dermatitis skin is driven by a balance of hyaluronan synthases 1 and 3. J Invest Dermatol (2014) 0.86
Relative importance of IL-4 and IL-13 in lesional skin of atopic dermatitis. Arch Dermatol Res (2004) 0.86
Pathogenesis of atopic dermatitis. Clin Exp Allergy (2015) 0.86
Hallmarks of atopic skin mimicked in vitro by means of a skin disease model based on FLG knock-down. Altern Lab Anim (2011) 0.85
Psychological Stress and the Cutaneous Immune Response: Roles of the HPA Axis and the Sympathetic Nervous System in Atopic Dermatitis and Psoriasis. Dermatol Res Pract (2012) 0.85